These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29423561)

  • 1. Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa.
    O'Driscoll NH; Cushnie TPT; Matthews KH; Lamb AJ
    Arch Microbiol; 2018 Jul; 200(5):793-802. PubMed ID: 29423561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
    Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
    Elife; 2021 Apr; 10():. PubMed ID: 33821795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    Sci Rep; 2021 Jan; 11(1):2151. PubMed ID: 33495505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
    Jones RN; Anderegg TR; Swenson JM;
    J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-sensitization of Multidrug-Resistant and Colistin-Resistant Gram-Negative Bacteria to Colistin by Povarov/Doebner-Derived Compounds.
    Onyedibe KI; Nemeth AM; Dayal N; Smith RD; Lamptey J; Ernst RK; Melander RJ; Melander C; Sintim HO
    ACS Infect Dis; 2023 Feb; 9(2):283-295. PubMed ID: 36651182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Yokota SI; Hakamada H; Yamamoto S; Sato T; Shiraishi T; Shinagawa M; Takahashi S
    Int J Antimicrob Agents; 2018 Jun; 51(6):888-896. PubMed ID: 29432867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli.
    Kubo A; Lunde CS; Kubo I
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1438-41. PubMed ID: 8726016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.
    Bock LJ; Hind CK; Sutton JM; Wand ME
    Lett Appl Microbiol; 2018 May; 66(5):368-377. PubMed ID: 29432643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial effect of rose bengal against colistin-resistant gram-negative bacteria.
    Kurosu M; Mitachi K; Pershing EV; Horowitz BD; Wachter EA; Lacey JW; Ji Y; Rodrigues DJ
    J Antibiot (Tokyo); 2023 Jul; 76(7):416-424. PubMed ID: 37076631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid screening of colistin-resistant Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa by the use of Raman spectroscopy and hierarchical cluster analysis.
    Lin Z; Zhao X; Huang J; Liu W; Zheng Y; Yang X; Zhang Y; Lamy de la Chapelle M; Fu W
    Analyst; 2019 Apr; 144(8):2803-2810. PubMed ID: 30882113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomally Encoded
    Snesrud E; Maybank R; Kwak YI; Jones AR; Hinkle MK; McGann P
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
    Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [No Abstract]   [Full Text] [Related]  

  • 20. The Mechanism of Killing by the Proline-Rich Peptide Bac7(1-35) against Clinical Strains of Pseudomonas aeruginosa Differs from That against Other Gram-Negative Bacteria.
    Runti G; Benincasa M; Giuffrida G; Devescovi G; Venturi V; Gennaro R; Scocchi M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.